False World Vs. Real World: A Strong Argument for RWD

Lucy Brake speaks to Mike Rea, CEO of IDEA Pharma, about how he believes real world evidence impacts current development and trials processes, and the ways in which pharma can take best take advantage of all this offers. Read entire article here. (Source: eyeforpharma, May 16, 2013)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
Real World Evidence (RWE) Solutions Market by Component,… 02/05/2020
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
Real-World Data Capabilities: Benchmarking Pharma Companies (2019) 09/26/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
The Future of Personalised Medicine: The Role of Simulation… 01/25/2020
Real World Data and Evidence: Payer Insights 09/26/2019